EmendoBio: Emendo Biotherapeutics to Present New Data at 63rd ASH Annual Meeting & Exhibition

(marketscreener.com) Emendo Biotherapeutics, a next-generation CRISPR company expanding the reach of gene editing therapeutics, will be presenting a poster at the annual American Society of Hematology conference in Atlanta, taking place December 11-14, 2021. The poster will present data from a CRISPR-based ex vivo strategy involving allele-specific excision of the...https://www.marketscreener.com/news/latest/Emendo-Biotherapeutics-to-Present-New-Data-at-63rd-ASH-Annual-Meeting-Exhibition--37250518/?utm_medium=RSS&utm_content=20211208